If the deal closes, the combined entity would be the top Medicaid provider in the nation, with 12.3 million members. Jefferies analyst David Windley told S&P the companies do have some material overlap in Florida, Georgia, Illinois and Missouri. A separate analyst on the conference call said the deal could raise some antitrust concerns, as Centene already controls a large share of the Medicaid market in several states.
“Centene has been more acquisitive and slowly edged itself toward the top five,” Mr. Windley told S&P. “This deal kind of makes it so you can’t think of them as one of the small guys anymore.” He added the merger could help Centene “leapfrog” over Humana when it comes to revenue.
In an interview with Bloomberg Law, Centene CEO Michael Neidorff said the insurer will have to divest some plans in two states where competition is limited in the Medicaid market.
“There are two states, Nebraska and Missouri, where there’s three plans, and WellCare’s one, we’re one,” Mr. Neidorff said April 4. “We know one of the plans is going to have to be divested.”
More articles on payers:
BCBS of Texas to open primary care clinics: 5 things to know
128,000 kids lost health insurance in Tennessee over 2 years — Here’s why
Pennsylvania woman denied coverage for sepsis-related foot amputation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.